Breaking News

AI in Healthcare: New Report into Regulation

Healthcare research company Paragon Health Institute has issued a significant new report on artificial intelligence(AI) in healthcare in the United States. The paper's title is Healthcare…

Other Headlines

Boston Scientific to Acquire Atrial Fibrillation Tech Company Cortex, Inc.

Boston Scientific says its acquisition of Cortex, Inc., will complement electrophysiology portfolio with solution to advance the treatment of complex atrial fibrillation. Privately held medical…

Valvosoft Non-Invasive Aortic Stenosis Therapy: Pivotal Study Results Promising

Cardiawave SA is the developer of the Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for the treatment of severe symptomatic calcific aortic stenosis (CAS). The company…

Thrombectomy Specialist Penumbra's Lightning Products CE Mark Makes Them Europe's Only CAVT Systems

Thrombectomy technology leader, Penumbra Inc. has secured CE Mark in Europe for the latest computer assisted vacuum thrombectomy (CAVT) devices. Background Penumbra is a frequent visitor…

Sensome Real-time, in situ Lung Tumor Confirmation System Study Enrols First Patients

French microsensing technology pioneer, Sensome has announced that the first eight patients have been enrolled in the first-in-human INSPECT study of its novel microsensor technology.…

ACURATE Prime™, Boston Scientific's New Aortic Valve System Gains CE Mark

Boston Scientific Corporation tells us it has obtained CE mark for the ACURATE Prime™ Aortic Valve System. Indeed it is…

Jupiter Endovascular Funding Means Green Light for Pulmonary Embolism Pivotal Trial

New funding will be used to support Jupiter Endovascular in its upcoming pivotal trial for Pulmonary Embolism. It will also aid development of additional clinical…

Insomnia Neurostimulation Tech on Show in China

A pioneering non-invasive neurostimulation technology for chronic insomnia will be showcased on the ABHI UK Pavilion at China’s CMEF 2024, which takes place in Shanghai,…

Emboliner ® IDE Study 100 Patient Milestone

The Emboliner “Protect the Head to Head” investigational device exemption (IDE) clinical trial has seen its one hundredth patient enrolled.…

VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark

Biosense Webster, Inc., has announced European CE mark approval of the VARIPULSE™ Platform. The approval covers the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF).…

Products

Foldax Signs Indian Manufacturer to Help Expedite Mitral Valve Commercialization in the Country

Heart Valve Pioneer Foldax® Inc., will see its innovative TRIA™ polymer mitral surgical heart valves being manufactured in India. A newly announced agreement with Dolphin Life…

Medovate and JEB Technologies Join Forces

East of England – based Medovate Ltd. and JEB Technologies Ltd., have become part of the same group structure. In effect their new collaboration will…

ABHI Warns that Unworkable HealthTech Procurement Means 1 in 3 Companies have Chosen to Not Bid on Tenders

A press release from the UK’s Association of British HealthTech Industries (ABHI) signals a warning for regulators and NHS procurement. Indeed it suggests that existing…

Regulatory

Medtech Regulatory and Commercial Landscape Considerations: UK, US, or EU first?

Feature article by Timothy Bubb, Medtech regulatory specialist and TechnicalDirector at IMed consultancy. Technology is taking an increasingly central place in healthcare. Drivers include advances…

Drug Eluting Stent Market Growth Predicted

The global drug eluting stent (DES) market size is expected to reach USD 13.65 billion by 2030, advancing at a CAGR of 8.4%. So says a new report from ResearchAndMarkets.com. The new report is entitled “Drug…

First O.U.S. Patients Get TRIA Biopolymer Surgical Aortic Valve™

Foldax®, Inc. says the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical aortic…

Companies

First-Ever Pivotal Trial of Synthetic Restorative Pulmonary Heart Valve

Based in Eindhoven, Netherlands, Xeltis is a clinical-stage developer of advanced polymer-based restorative cardiovascular devices. The company has now announced the start of the first-ever…

UK Innovations Launched at Arab Health 2020

The Association of British HealthTech Industries (ABHI) has revealed some of what it describes as ground-breaking digital health technologies, services and products being launched at…

Non-Invasive Headache Therapy System Selected for NHS England Innovation and Technology Payment Program

electroCore, Inc., a commercial-stage bioelectronic medicine company, tells us that its gammaCore non-invasive vagus nerve stimulator (nVNS), has been selected for the Innovation and Technology Payment (ITP) Program by NHS England for use in the…